MADRID, 29 Sep. (EUROPA PRESS) –
Atrys Health recorded attributed losses of 23 million euros in the first half of this year, a figure seven times higher than the ‘red numbers’ of 3.1 million euros in the same period of the previous year, as reported this Friday by the firm. the National Securities Market Commission (CNMV).
The company achieved a turnover of 118.23 million euros during the first half of this year, 33% above the 88.9 million euros registered in the same period of 2022.
In addition, Atrys recorded a gross operating result (Ebitda) of 22.6 million euros until June, 34.8% more, while its adjusted Ebitda grew to 25.7 million euros, which represents an increase of 21.4%.
The gross margin for the first half of 2023 stood at 86 million euros, 15.4% more than in the same period of the previous year.
The investment in ‘capex’ reached 6.9 million euros, of which 2.3 million correspond to the expansion linked to the openings of new production centers, as highlighted by the firm in a press release.
Atrys Health has signed an agreement this week with Salud Interactiva, a Mexican company owned by the Inbursa Financial Group, owned by Mexican magnate Carlos Slim, for the joint development of various health projects in Mexico, within the framework of its expansion strategy in the country.
